Suppr超能文献

使用骨关节同种异体移植行切除关节固定术保肢治疗膝关节周围侵袭性骨巨细胞瘤

Limb Salvage by Resection Arthrodesis with the use of Osteoarticular Allograft in the Treatment of Aggressive Giant Cell Tumour around the Knee.

作者信息

Datta N K, Das K P, Mia M M, Aish P K

机构信息

Professor Dr Nakul Kumar Datta, Chairman, Department of Orthopaedic Surgery, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbagh, Dhaka, Bangladesh; E-mail:

出版信息

Mymensingh Med J. 2020 Apr;29(2):317-324.

Abstract

Osteoarticular allografts have provided the chance of limb-sparing trial in tumor surgery. Several authors have reported 50-75% long term (>10 years) successful use of these types of grafts, and large well recognized series provide confirmation that limb reconstruction following extensive resection of bone and joints has been possible with their use. Infection has been a major problem, affecting up to 12 per cent of recipients and often resulting in re-operations and infrequently amputations. This prospective Interventional study was conducted in the Department of Orthopaedic Surgery, Bangabandhu Sheikh Mujib Medical University (BSMMU) and Biomedical Research division, Atomic Energy Centre, Savar, Dhaka, Bangladesh from January 2008 to December 2017. In this study patients' age were 20-50 years and male was 12(60%) & female was 8(40%). We assessed the results of 20 limb-salvage procedures (Resection-Arthrodesis Procedure) using 11-18cm of distal femur or proximal tibial osteoarticular allografts after wide resection of aggressive or malignant Giant Cell Tumour (GCT) around the knee joint, Campanacci Grade III or recurrent case of Campanacci Grade II. At the ten-year follow-up, two patients had died, one due to infection and tumor metastasis to the lungs and one due to medical causes. The allografts survived for more than five years was twelve patients (60%) all of whom had good function, ranging from 73% to 90% of normal. The allografts were removed because of fracture in two patients and infection in two patients. Remaining three patients allograft was survived with satisfactory function but follow up was 3 years. All postoperative problems related to the allograft reconstruction were documented. Functional outcome was evaluated using the Musculoskeletal Tumour Society Scoring System and at least more than 3 years follow up should be taken for categorization of the results. Among the 20 patients, satisfactory result was 15(75%) patients and unsatisfactory result was 5(25%) patients. P value was <0.001.

摘要

骨关节同种异体移植为肿瘤手术中的保肢试验提供了机会。几位作者报告称,这些类型的移植物长期(>10年)成功使用率为50%-75%,大型知名系列研究证实,使用它们可以在广泛切除骨骼和关节后进行肢体重建。感染一直是一个主要问题,影响高达12%的接受者,常常导致再次手术,很少需要截肢。这项前瞻性干预研究于2008年1月至2017年12月在孟加拉国达卡萨瓦尔原子能中心生物医学研究部和班加班杜·谢赫·穆吉布医科大学(BSMMU)骨科进行。在这项研究中,患者年龄为20-50岁,男性12名(60%),女性8名(40%)。我们评估了20例保肢手术(切除-关节固定术)的结果,这些手术是在膝关节周围广泛切除侵袭性或恶性骨巨细胞瘤(GCT)、坎帕纳奇三级或坎帕纳奇二级复发病例后,使用11-18厘米的股骨远端或胫骨近端骨关节同种异体移植物。在十年随访中,两名患者死亡,一名死于感染和肿瘤肺转移,一名死于医疗原因。同种异体移植物存活超过五年的有12名患者(60%),所有这些患者功能良好,相当于正常功能的73%至90%。两名患者因骨折、两名患者因感染而取出同种异体移植物。其余三名患者的同种异体移植物存活,功能满意,但随访时间为3年。记录了与同种异体移植重建相关的所有术后问题。使用肌肉骨骼肿瘤学会评分系统评估功能结果,结果分类至少应进行3年以上的随访。在20名患者中,满意结果为15名(75%)患者,不满意结果为5名(25%)患者。P值<0.001。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验